Protocol GRN163LMYF3001
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Geron Corporation
Start Date
February 22, 2022
End Date
March 31, 2027
Administered By
Duke Cancer Institute
Awarded By
Geron Corporation
Start Date
February 22, 2022
End Date
March 31, 2027